Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Card Fail. 2012 Feb 2;18(3):176–182. doi: 10.1016/j.cardfail.2011.12.009

Table 3.

Stepped Pharmacologic Care Treatment Algorithm

Urine output (UO) goals to be assessed daily from randomization to 96 hours
 UO > 5 L/d → Reduce current diuretic regimen if desired
 UO 3–5 L/d → Continue current diuretic regimen
 UO < 3 L/d → See diuretic grid
24-hour assessment
 UO recommendations as above
 Advance to next step on grid if UO < 3 L/d
48-hour assessment
 UO recommendations as above
 Advance to next step on grid if UO < 3 L/d
 Consider dopamine or dobutamine at 2 μg/kg/h if SBP < 110 mm Hg and EF <40% or RV systolic dysfunction.
 Consider nitroglycerin or nesiritide if SBP > 120 mm Hg (any EF) and severe symptoms
72- and 96-hour assessments
 UO recommendations as above
 Advance to next step on grid if UO < 3 L/d
 Consider dopamine or dobutamine at 2 μg/kg/hr if SBP < 110 mm Hg and EF <40% or RV systolic dysfunction.
 Consider nitroglycerin or nesiritide if SBP > 120 mm Hg (any EF) and severe symptoms
 Consider hemodynamic guided IV therapy, LVAD, dialysis, or ultrafiltration crossover
Diuretic Grid
Suggested Dose
Current Dose Daily Loop Dose Thiazide
A <80 mg 40 mg IV bolus + 5 mg/h None
B 81–160 mg 80 mg IV bolus + 10 mg/h 5 mg metolazone once daily
C 161–240 mg 80 mg IV bolus + 20 mg/h 5 mg metolazone twice daily
D >240mg 80 mg IV bolus + 30 mg/h 5 mg metolazone twice daily

SBP, systolic blood pressure; EF, ejection fraction; RV, right ventricle; LVAD, left ventricular assist device; Loop, loop diuretic dose in furosemide equivalents.